Miglustat HCl (N-Butyldeoxynojirimycin) is a small molecule which can act as an a-Glucosidase inhibitor. It is provided as a powder. This product acts on the following target types: Glycosidase. This product acts on the following biochemical pathways: Carbohydrate metabolism, Sphingolipid metabolism. This product may be of interest in the following research areas and diseases: Neuroscience. This product may act as a Coronavirus inhibitor: Inhibits galactosidase alpha (GLA), which interacts with SARS-CoV-2 Nsp14; analog of IHVR-19029, and antiviral in clinical trials. Please note that our chemical products are for scientific research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
Target
Miglustat HCl (N-Butyldeoxynojirimycin)
Form
Solid
Purity
> 98%
Reconstitution
Soluble in DMSO (up to 20 mg/ml) or in Water (up to 20 mg/ml).
Storage
Store desiccated at -20°C. Solutions can be stored at -20°C for up to 1 month.
Shelf Life
Up to 12 months.
Molecular Weight
255.7 g/mol
Molecular Formula
C10H21NO4 HCl
Buffer
Not applicable.
CAS Number
210110-90-0
Availability
Shipped within 5-10 working days.
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
We use cookies necessary for the function of our website, to improve your experience, analyse our traffic, and cookies that optimise the performance. To learn more about our cookies, please read our Cookie Notice.